Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $39.8200 (-0.85%) ($39.7100 - $40.5750) on Mon. Feb. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.59% (three month average) | RSI | 27 | Latest Price | $39.8200(-0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.6% a day on average for past five trading days. | Weekly Trend | BAX declines -3.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(34%) SPLV(33%) IWD(32%) XLRE(31%) ARKG(30%) | Factors Impacting BAX price | BAX will decline at least -1.295% in a week (0% probabilities). VIXM(-25%) GLD(-20%) VXX(-13%) SHY(-8%) FXI(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.295% (StdDev 2.59%) | Hourly BBV | -1.7 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $42.44 | 5 Day Moving Average | $40.44(-1.53%) | 10 Day Moving Average | $40.35(-1.31%) | 20 Day Moving Average | $42.44(-6.17%) | To recent high | -29.6% | To recent low | 0.1% | Market Cap | $20.315b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |